Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: Nexium 20mg; Drug: Nexium 10mg Sponsors: AstraZeneca; IQVIA RDS Inc.; Calyx; Labcorp Central Laboratory Services; Medidata Solutions; Thermo Fisher Scientific; CISCRP (Center for Information and Study on Clinical Research Participation); Quipment Inc.; Little Journey Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2022 Category: Research Source Type: clinical trials
Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants
Condition: Gastrointestinal Diseases Interventions: Drug: Esomeprazole 20 mg Delayed-Release Capsules; Drug: Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR) Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2022 Category: Research Source Type: clinical trials